ArticleInternational journal of clinical practice2024

Comparison of Efficacy and Safety of First-Line Treatment Options for Unresectable Stage III Non-Small Cell Lung Cancer: A Retrospective Analysis.

Luqing Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.